We hypothesized the AMPK-HDAC5 regulatory pathway, previously studied in diabetes and cardiovascular disease,23 may be involved with the reduction of HDAC5 levels in WD mice, since activated AMPK signaling has been reported in animal models of copper accumulation.24 This evidence concerns the gene HDAC5 and Wilson disease.